Related Experiment Video

Updated: Apr 28, 2026

Assessing Cellular Stress and Inflammation in Discrete Oxytocin-secreting Brain Nuclei in the Neonatal Rat Before and After First Colostrum Feeding
09:12

Assessing Cellular Stress and Inflammation in Discrete Oxytocin-secreting Brain Nuclei in the Neonatal Rat Before and After First Colostrum Feeding

Published on: November 14, 2018

7.1K

Effects of oxytocin used during delivery on development: a retrospective cohort study

María José González-Valenzuela1, Pedro García-Fortea, Myriam Delgado-Ríos

  • 1a Department of Developmental and Educational Psychology, Faculty of Psychology , University of Málaga , Málaga , Spain.

Journal of Clinical and Experimental Neuropsychology
|June 12, 2014
PubMed

Insights

Oxytocin during delivery did not significantly impact overall child development at age 5. However, specific birth types and maternal ages showed varied effects on developmental outcomes, warranting further investigation.

Area of Science:

  • Perinatal medicine
  • Developmental pediatrics
  • Obstetrics

Background:

  • Oxytocin is commonly administered during labor and delivery.
  • The long-term effects of synthetic oxytocin on child development are not fully understood.
  • Understanding these effects is crucial for informed clinical practice.

Purpose of the Study:

  • To investigate the association between oxytocin use during delivery and children's developmental outcomes at age 5.
  • To identify potential moderating factors such as maternal age and delivery type.
  • To provide evidence-based insights into the safety of oxytocin in obstetrics.

Main Methods:

  • Retrospective cohort study design.
  • Inclusion of 148 children evaluated using the Battelle Developmental Inventory at age 5.
  • Analysis of confounding factors using stratified and multivariate logistic regression.

Main Results:

  • Overall oxytocin use showed no significant association with developmental delay (RR 1.46, CI [0.79-2.71]).
  • In noninstrumental vaginal deliveries, oxytocin increased risk for poor outcomes in mothers <28 or >35 years (OR 67.14, CI [5.46-824.86]).
  • In instrumental/cesarean deliveries for mothers aged 28-35, oxytocin decreased risk (OR 0.16, CI [0.04-0.66]).

Conclusions:

  • Oxytocin administration during delivery did not universally increase the risk of developmental delay.
  • Maternal age and delivery type significantly modify the association between oxytocin and developmental outcomes.
  • Further research is needed to elucidate the nuanced effects of oxytocin in different obstetric scenarios.
Abstract

Keywords:
Battelle InventoryPsychological development disabilityRetrospective cohort studySynthetic oxytocinUterine stimulants

More Related Videos

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development07:56

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development

Published on: January 26, 2018

20.0K
Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling07:11

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling

Published on: February 5, 2019

8.9K

Related Concept Videos

Neurotransmitters01:31

Neurotransmitters

Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
3.9K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
65
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
1.0K